DrugCite
Search

NEO MERCAZOLE TAB

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Neo Mercazole Tab Adverse Events Reported to the FDA Over Time

How are Neo Mercazole Tab adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Neo Mercazole Tab, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Neo Mercazole Tab is flagged as the suspect drug causing the adverse event.

Most Common Neo Mercazole Tab Adverse Events Reported to the FDA

What are the most common Neo Mercazole Tab adverse events reported to the FDA?

Agranulocytosis
14 (2.65%)
Hyperthyroidism
10 (1.89%)
Dyspnoea
9 (1.7%)
Oedema Peripheral
8 (1.51%)
Pyrexia
8 (1.51%)
Renal Failure Acute
8 (1.51%)
White Blood Cell Count Decreased
8 (1.51%)
Bronchitis
7 (1.32%)
Interstitial Lung Disease
7 (1.32%)
Neutropenia
7 (1.32%)
C-reactive Protein Increased
6 (1.13%)
Show More Show More
Depressed Level Of Consciousness
6 (1.13%)
Encephalopathy
6 (1.13%)
Hepatic Failure
6 (1.13%)
Hypothyroidism
6 (1.13%)
Eye Disorder
5 (.95%)
Febrile Neutropenia
5 (.95%)
General Physical Health Deteriorati...
5 (.95%)
Hypercapnia
5 (.95%)
Metabolic Alkalosis
5 (.95%)
Platelet Count Decreased
5 (.95%)
Toxic Epidermal Necrolysis
5 (.95%)
Anaemia
4 (.76%)
Asterixis
4 (.76%)
Blood Alkaline Phosphatase Increase...
4 (.76%)
Cerebellar Syndrome
4 (.76%)
Cholestasis
4 (.76%)
Cytolytic Hepatitis
4 (.76%)
Erythema
4 (.76%)
Hypotension
4 (.76%)
Infection
4 (.76%)
Jaundice Cholestatic
4 (.76%)
Leukopenia
4 (.76%)
Neutrophil Count Decreased
4 (.76%)
Pharyngitis
4 (.76%)
Renal Failure
4 (.76%)
Rheumatoid Arthritis
4 (.76%)
Aphthous Stomatitis
3 (.57%)
Biliary Cirrhosis
3 (.57%)
Blood Bilirubin Increased
3 (.57%)
Blood Lactate Dehydrogenase Increas...
3 (.57%)
Caesarean Section
3 (.57%)
Cardiomegaly
3 (.57%)
Coma Hepatic
3 (.57%)
Condition Aggravated
3 (.57%)
Conjunctival Disorder
3 (.57%)
Conjunctivitis Infective
3 (.57%)
Cough
3 (.57%)
Delirium
3 (.57%)
Diarrhoea
3 (.57%)
Haemoglobin Decreased
3 (.57%)
Hepatic Encephalopathy
3 (.57%)
Hepatorenal Syndrome
3 (.57%)
Hyperthermia
3 (.57%)
Lactic Acidosis
3 (.57%)
Malaise
3 (.57%)
Musculoskeletal Stiffness
3 (.57%)
Oral Disorder
3 (.57%)
Oropharyngeal Pain
3 (.57%)
Orthostatic Hypotension
3 (.57%)
Pleural Effusion
3 (.57%)
Pruritus
3 (.57%)
Rales
3 (.57%)
Rash Vesicular
3 (.57%)
Rectal Haemorrhage
3 (.57%)
Skin Disorder
3 (.57%)
Skin Lesion
3 (.57%)
Thrombocytopenia
3 (.57%)
Thyroid Disorder
3 (.57%)
Alanine Aminotransferase Increased
2 (.38%)
Arthralgia
2 (.38%)
Aspartate Aminotransferase Increase...
2 (.38%)
Asthenia
2 (.38%)
Atrial Fibrillation
2 (.38%)
Autoimmune Hepatitis
2 (.38%)
Balance Disorder
2 (.38%)
Bicytopenia
2 (.38%)
Blindness Unilateral
2 (.38%)
Blood Creatinine Increased
2 (.38%)
Blood Glucose Increased
2 (.38%)
Blood Pressure Decreased
2 (.38%)
Breech Presentation
2 (.38%)
Cerebral Haemorrhage
2 (.38%)
Cholelithiasis
2 (.38%)
Disturbance In Attention
2 (.38%)
Drug Exposure During Pregnancy
2 (.38%)
Drug Interaction
2 (.38%)
Exophthalmos
2 (.38%)
Eye Pain
2 (.38%)
Fatigue
2 (.38%)
Foetal Distress Syndrome
2 (.38%)
Heart Rate Increased
2 (.38%)
Hepatic Steatosis
2 (.38%)
Hepatitis Chronic Active
2 (.38%)
Hepatitis Toxic
2 (.38%)
Jaundice Hepatocellular
2 (.38%)
Loss Of Consciousness
2 (.38%)
Lymphadenopathy
2 (.38%)
Maternal Drugs Affecting Foetus
2 (.38%)
Mental Disorder
2 (.38%)
Metabolic Acidosis
2 (.38%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Neo Mercazole Tab, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Neo Mercazole Tab is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Neo Mercazole Tab

What are the most common Neo Mercazole Tab adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Neo Mercazole Tab, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Neo Mercazole Tab is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Neo Mercazole Tab According to Those Reporting Adverse Events

Why are people taking Neo Mercazole Tab, according to those reporting adverse events to the FDA?

Hyperthyroidism
87
Basedows Disease
34
Product Used For Unknown Indication
14
Drug Use For Unknown Indication
10
Fatigue
5
Hypothyroidism
4
Show More Show More
Toxic Nodular Goitre
3
Goitre
3
Ill-defined Disorder
2
Thyroid Disorder
2
Bipolar Disorder
1
Unevaluable Event
1
Drug Exposure During Pregnancy
1
Thyroiditis
1
Liver Transplant
1
Thyroiditis Subacute
1

Neo Mercazole Tab Case Reports

What Neo Mercazole Tab safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Neo Mercazole Tab. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Neo Mercazole Tab.